Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia

Life Sciences

Volumn 100, Issue 2, 2014, Pages 97-109

  Bhattacharya, Pallab ^a,b   Pandey, Anand Kumar ^b   Paul, Sudip ^b,c   Patnaik, Ranjana ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BANARAS HINDU UNIVERSITY   (India)

^c NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Aquaporin 4; Brain edema; Melatonin; Neuroprotection; Protein kinase C

Indexed keywords

AQUAPORIN 4; MALONALDEHYDE; MELATONIN; NITRITE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL DEATH; CHEMICAL ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION; WATER CONTENT; WESTERN BLOTTING;

ANIMALIA; RATTUS;

AQUAPORIN-4; BRAIN EDEMA; MELATONIN; NEUROPROTECTION; PROTEIN KINASE C;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; AQUAPORIN 4; BLOTTING, WESTERN; BRAIN EDEMA; BRAIN ISCHEMIA; CALCIUM; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; MALE; MALONDIALDEHYDE; MELATONIN; NEUROPROTECTIVE AGENTS; NITRITES; PROTEIN KINASE C; RATS; RATS, INBRED STRAINS; REPERFUSION INJURY; STROKE;

EID: 84897101210     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.01.085     Document Type: Article

References (82)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
2. Amiry-Moghaddam M, Otsuka T, Hurn PD. An α-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci U S A 2003;100:2106-11. (Pubitemid 36254581)
3. Antezana DF, Clatterbuck RE, Alkayed NJ, Murphy SJ, Anderson LG, Frazier J, et al. High-dose ibuprofen for reduction of striatal infarcts during middle cerebral artery occlusion in rats. J Neurosurg 2003;98:860-6. (Pubitemid 36396790)
4. Badaut J, Brunet JF, Grollimund L, et al. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl 2003;86:495-8.
5. Benitez-King G, Badaut J, Brunet JF, Grollimund L, Hamou MF, Magistretti PJ, et al. PKC activation by melatonin modulates vimentin intermediate filament organization in N1E-115 cells. J Pineal Res 2000;29:8-14.
6. Bhattacharya P, Pandey AK, Paul S, Patnaik R. Neuroprotective potential of Piroxicam in cerebral ischemia: an in-silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of Aquaporin-4 and Acid Sensing Ion Channel 1a. Med Hypotheses 2012;79:352-7.
7. Borlongan CV, Yamamoto M, Takei N, Kumazaki M, Ungsuparkorn C, Hida H, et al. Glial cell survival is enhanced duringmelatonin-ind uced neuroprotection against cerebral ischemia. FASEB J 2000;14:1307-17. (Pubitemid 30439739)
8. BradfordMM. A rapid and sensitivemethod for the quantitation ofmicrogramquantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
9. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke 2009;40:331-9.
10. Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 1999;12:2704-12.
11. Caspera D, Yaparpalvia U, Rempelb N, Werner P. Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci Lett 2000;289(3):201-4. (Pubitemid 30657973)
12. Cho BB, Toledo-Pereyra LH. Caspase-independent programmed cell death following ischemic stroke. J Invest Surg 2008;21:3141-7.
13. Cho S, Joh TH, Baik HH, Dibinis C, Volpe BT. Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats. Brain Res 1997;755:335-8. (Pubitemid 27196340)
14. Chueng RTF. The utility ofmelatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003;34:153-60.
15. Drago FO, Macauda S, Salehi S. Small doses of melatonin increase intestinal motility in rats. Dig Dis Sci 2002;47(9):1969-74. (Pubitemid 35024806)
16. Dubbels R, Reiter RJ, Klenke E, Goebel A, Schnakenberg E, Ehlers C, Schiwara HW, et al. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res 1995;18:28-31.
17. Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc (Baltim) 1957;46:208-9.
18. Fan Y, Zhang J, Sun XL, Gao L, Zeng XN, Ding JH, et al. Sex and region-specific alterations of basal aminoacid andmonoamino in the brain of AQP4 knock-outmice. J Neurosci Res 2005;82:458-64. (Pubitemid 41579345)
19. Fiorina P, Lattuada G, Ponari O, Silvestrini C, Dall'Aglio P. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 1996;347:692-3. (Pubitemid 26076152)
20. Friedman CS, Philbert ST, Andy YS, Katerina A, David K, Patrick DL. Acute vascular disruption and aquaporin 4 loss after stroke. Stroke 2009;40:2182-90.
21. Frydenlund DS, Bhardwaj A, Otsuka T, Mylonakou MN, Yasumura T, Davidson KG, et al. Temporary loss of perivascular aquaporin-4 in neocortex after transientmiddle cerebral artery occlusion in mice. Proc Natl Acad Sci U S A 2006a;103:13532-6. (Pubitemid 44380142)
22. Frydenlund DS, Bhardwaj A, Otsuka T, Mylonakou MN, Yasumura T, Davidson KGV, et al. Temporary loss of perivascular aquaporin-4 in neocortex after transientmiddle cerebral artery occlusion in mice. Proc Natl Acad Sci U S A 2006b;103:13532-6. (Pubitemid 44380142)
23. Goodsell DS, Olson AJ. Automated docking of substrates to proteins by simulated annealing proteins. Struct Funct Genet 1990:195-202.
24. Görgülü A, Palaoǧlu S, Ismailoǧlu O, Tuncel M, Sürücü MT, Erbil M, et al. Effect of melatonin on cerebral edema in rats. Neurosurgery 2001a;49:1434-41.
25. Görgülü A, Palaoǧlu S, Ismailoǧlu O, Tuncel M, Sürücü MT, Erbil M, et al. Effect of melatonin on cerebral edema in rats. Neurosurgery 2001b;49:1434-41.
26. Gueniau C, Oberlander C. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke. J Pharmacol Exp Ther 1997;282:1-6. (Pubitemid 27425520)
27. Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, Anna P, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998;274:177-88. (Pubitemid 28269300)
28. Gul S, Celik SE, Kalayci M, Tasyurekli M, Cokar N, Bilge T. Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats. Surg Neurol 2005;64:355-61.
29. Gunnarson E, Zelenina M, Aperia A. Regulation of brain aquaporins. Neuroscience 2004;129:947-55. (Pubitemid 39556246)
30. Gupta RK, Kanungo M. Glial molecular alterations with mouse brain development and aging: up-regulation of the Kir4.1 and aquaporin-4. Age 2011:9330-5.
31. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992;119:598-620.
32. Han BC, Koh SB, Lee EY, Seong YH. Regional difference of glutamate-induced swelling in cultured rat brain astrocytes. Life Sci 2004;76:573-83. (Pubitemid 39535668)
33. Hara H, Huang PL, Panahian N, Fishman MC, Moskowitz MA. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 1996;16:605 -11.
34. Haydn NA, Jasmine MH. Use of the narrow beam test in the rat, 6 hydroxydopamine model of Parkinson's disease. J Neurosci Methods 2007;159:195-202.
35. Hirata H, Asanuma M, Cadet JL. Melatonin attenuates methamphetamine- induced toxic effects on dopamine and serotonin terminals in mouse brain. Synapse 1998;30:150-5. (Pubitemid 28376373)
36. Iacovitti L, Stull ND, Johnston K. Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res 1997;768:317-26. (Pubitemid 27433507)
37. Jagota SK, Dani HM. A new colorimetric technique for the estimation of vitamin C using folin phenol reagent. Anal Biochem 1982;127:178-82. (Pubitemid 13155103)
38. Jollow DJ, Mitchell JR, Zampaglione N. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974;11:151-69.
39. Joo JY, Uz T, Manev H. Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat. Restor Neurol Neurosci 1998;13:185-91. (Pubitemid 29015954)
40. Jou MJ, Peng TI, Hsu LF, Jou SB, Reiter RJ, Yang CM, et al. Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2 +)-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010;48:20-38.
41. Kaur C, Sivakumar V, Zhang Y, Ling EA. Hypoxia-induced astrocytic reaction and increased vascular permeability in the rat cerebellum. Glia 2006;54:826-39. (Pubitemid 44671988)
42. Kilic E, Ozdemir YG, Bolay H, Keleştimur H, Dalkara T. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 1999;19:511-6. (Pubitemid 30159813)
43. Kilic U, Yilmaz B, Ugur M, Yüksel A, Reiter RJ, Hermann DM, et al. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012;52:228-35.
44. Kleindienst A, Fazzina G, Amorini AM, Dunbar JG, Glisson R, Marmarou A. Modulation of AQP4 expression by the protein kinase C activator, phorbol myristate acetate, decreases ischemia-induced brain edema. Acta Neurochir Suppl 2006;96: 373-7.
45. Kondoh T, Uneyama H, Nishino H, Torii K. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life Sci 2002;72:583-90. (Pubitemid 35452560)
46. Kovalenko T, Osadchenko I, Nikonenko A. Ischemia inducedmodifications in hippocampal CA1 stratum radiatum excitatory synapses. Hippocampus 2006;16:814-25. (Pubitemid 44650899)
47. Leon J, Acuna-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005;38:1-9. (Pubitemid 40139304)
48. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000;17:871-90.
49. Li PK, Witt-Enderby PA. Melatonin receptors as potential targets for drug discovery. Drugs Future 2000;25:945-57.
50. Lievre V, Bechuwe P, Bianchi A, Bossenmeyer P, Koziel V, Franck VP, et al. Intracellular generation of free radicals andmodifications of detoxifying enzymes in cultured neurons from the developing rat forebrain in response to transient hypoxia. Neuroscience 2001;105:287-97. (Pubitemid 32728113)
51. Chen Liu, Sang Jun-Le, Han-Fei Lu, Dong Yan, Xiong Hai-Long, Wang Li-Ze. Therapeutic time window of flurbiprofen axetil's neuroprotective effect in a ratmodel of transient focal cerebral ischemia. Chin Med J 2008;121:2572.
52. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91. (Pubitemid 19040218)
53. Manley GT, Binder DK, Papadopoulos MC, Verkman AS. Newinsights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 2004;129:983-91. (Pubitemid 39556249)
54. Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, DietrichWD, McCabe PM, et al. Sensori-motor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res 1992;575:238-46.
55. Matuszak Z, Reszka KJ, Chignell CF. Reaction of melatonin and related indoles with hydroxy radicals: EPR and spin trapping investigations. Free Radic Biol Med 1997;23:367-72. (Pubitemid 27276772)
56. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden L, Pablos MI, Tan DX. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993;53:373-82. (Pubitemid 24043036)
57. Moran PM, Higgins LS, Cordell B, Moser PC. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci U S A 1957;92:5341-5.
58. Moroni F. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. Curr Opin Pharmacol 2008;8:96-103. (Pubitemid 351168695)
59. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 1998;19:139-1662.
60. Nelson SK, Bose SK, McCord JM. The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med 1994;16:195-200. (Pubitemid 24117500)
61. Oberley LW, Spitz DR. Assay of superoxide dismutase activity in tumor tissue. Methods Enzymol 1984;105:457-64. (Pubitemid 14165412)
62. Papadopoulos MC, Krishna S, Verkman AS. Aquaporin water channels and brain edema. Mt Sinai J Med 2002;69:242-8. (Pubitemid 34965808)
63. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010;48:297 -310.
64. Pei Z, Pang SF, Cheung RTF. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke 2003;34:770-5. (Pubitemid 36307409)
65. Phillis JW, O'Regan MH. Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. Neurochem Int 2003;43:461-7. (Pubitemid 36561300)
66. 2-dependence of phospholipase C in the cat carotid body. Adv Exp Med Biol 1993;337:191-5.
67. Popp A, Jaenisch N, Witte OW, Frahm C. Identification of ischemic regions in a rat model of stroke. PLoS One 2009;4:47-64.
68. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991;12:151-80.
69. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998;56:359-84. (Pubitemid 28389724)
70. Reiter R, Tang L, Garcia JJ, Muñoz-Hoyos A. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995;18:1-11.
71. Reiter RJ, Guerrero JM, Escames G, Pappolla MA, Acuña-Castroviejo D. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997;60:2255-71.
72. Reiter RJ, Guerrero JM, Escames G, PappollaMA, Acuña-Castroviejo D. Prophylactic actions of melatonin in oxidative neurotoxicity. Ann N Y Acad Sci 1997;825:70-8. (Pubitemid 27503707)
73. Sinha K, Degaonkar MN, Jagannathan NR, Gupta YK. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 2001;428:185-92. (Pubitemid 33000140)
74. Song GH, Gwee KA, Moochhala SM, Ho KY. Melatonin attenuates stress-induced defecation: lesson from a rat model of stress-induced gut dysfunction. Neurogastroenterol Motil 2005;17:744-50. (Pubitemid 41400724)
75. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 2005;11:308-22. (Pubitemid 41040860)
76. Tan DX, Chen L-D, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
77. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM, et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003;34:75-8.
78. Torii K, Uneyama H, Nishino H, Kondoh T. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J Pineal Res 2004;36:18-24. (Pubitemid 38130285)
79. Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S, Melan MA. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 2003;72:2183-98. (Pubitemid 36292142)
80. Yatsushige H, Ostrowski RP, Tsubokawa T, Colohan A, Zhang JH. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. J Neurosci Res 2007;85:1436-48. (Pubitemid 46724387)
81. Yeleswaram K, McLaughlin LG, Knipe JO, Schabdach D. Pharmacokinetics and oral bio-availability of exogenousmelatonin in preclinical animalmodels and clinical implications. J Pineal Res 1997;22:45-51. (Pubitemid 127731790)
82. Yon JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006;21:522-30. (Pubitemid 43277535)